AnaptysBio, Inc. (ANAB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -25.92M | 98M | -27.36M | -40.24M | -10.7M | -66.67M | -10.09M | -21.32M | -37.25M | -34.35M | -36.47M | -25.41M |
| Operating CF Margin % | -101.42% | 90.53% | -35.84% | -180.77% | -38.53% | -154.64% | -33.61% | -194.35% | -518.92% | -381.44% | -1099.28% | -734.36% |
| Operating CF Growth % | -142.23% | 246.98% | -171.12% | -88.74% | 71.28% | -94.1% | 72.34% | 16.08% | -51.63% | -221.47% | -105.52% | -5.23% |
| Net Income | -52.88M | 49.61M | 15.11M | -38.63M | -39.33M | -21.78M | -32.85M | -46.66M | -43.94M | -42.21M | -37.31M | -39.84M |
| Depreciation & Amortization | 610K | 606K | 610K | 601K | 606K | 601K | 596K | 595K | 605K | 604K | 592K | 587K |
| Stock-Based Compensation | 14.22M | 8.51M | 9.16M | 9.24M | 9.17M | 8.18M | 8.19M | 7.54M | 10.13M | 8.11M | 7.81M | 8.43M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.15M | -2.99M | 0 |
| Other Non-Cash Items | 19.84M | 19.37M | 21.39M | 18.01M | 16.39M | 15.1M | 15.3M | 8.48M | 3.35M | 4.96M | 4.43M | 2.17M |
| Working Capital Changes | -7.71M | 19.9M | -73.62M | -29.46M | 2.46M | -68.78M | -1.32M | 8.72M | -7.4M | -2.66M | -9M | 3.25M |
| Change in Receivables | 8.1M | 41.84M | -54.27M | -3.53M | 22.88M | -28.57M | 2.16M | -1.92M | -238K | -3.58M | -87K | -1.66M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -17.82M | -22.41M | -18.56M | -22.32M | -24.03M | -40.05M | 3.36M | 8.02M | -5.17M | -1.5M | -2.7M | 6.61M |
| Cash from Investing | 34.98M | 73.5M | 103.28M | 36.4M | 14.85M | -29.4M | 58.62M | -2.44M | 68.62M | 49.18M | 30.64M | -20.45M |
| Capital Expenditures | -17K | -1K | -12K | -39K | -35K | -263K | -35K | -33K | -27K | -280K | -162K | -190K |
| CapEx % of Revenue | 0.07% | 0% | 0.02% | 0.18% | 0.13% | 0.61% | 0.12% | 0.3% | 0.38% | 3.11% | 4.88% | 5.49% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -49.46M | -30.8M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.46M | 30.8M | 0 |
| Cash from Financing | 1.21M | -43.13M | -10.39M | -50.5M | -28.59M | 27.57M | 71.23M | 41.89M | -13.63M | -5.16M | -3.07M | -13.49M |
| Debt Issued (Net) | -12.81M | -51.96M | -1.01M | -823K | 0 | 0 | -26.9M | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 14.02M | 8.83M | -9.38M | -49.67M | -4.13M | 99K | 98.5M | 979K | 811K | 264K | 160K | -11.69M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -3.38M | -9.72M | -51.1M | -4.42M | -456K | 0 | 0 | 0 | 0 | 0 | -12.47M |
| Other Financing | 0 | 0 | 0 | 0 | -24.46M | 27.47M | -370K | 40.91M | -14.44M | -5.42M | -3.23M | -1.8M |
| Net Change in Cash | 10.27M | 128.36M | 65.53M | -54.34M | -24.44M | -68.5M | 119.76M | 18.13M | 17.73M | 9.67M | -8.91M | -59.36M |
| Free Cash Flow | -25.94M | 98M | -27.37M | -40.28M | -10.73M | -66.94M | -10.13M | -21.36M | -37.28M | -34.63M | -36.64M | -25.6M |
| FCF Margin % | -101.49% | 90.53% | -35.86% | -180.94% | -38.66% | -155.25% | -33.73% | -194.65% | -519.29% | -384.55% | -1104.16% | -739.86% |
| FCF Growth % | -141.6% | 246.4% | -170.3% | -88.63% | 71.2% | -93.29% | 72.36% | 16.58% | -50.67% | -218.87% | -105.85% | -5.67% |
| FCF per Share | -0.90 | 3.13 | -0.94 | -1.40 | -0.35 | -2.20 | -0.35 | -0.78 | -1.39 | -1.30 | -1.38 | -0.96 |
| FCF Conversion (FCF/Net Income) | 0.49x | 1.98x | -1.81x | 1.04x | 0.27x | 3.06x | 0.31x | 0.46x | 0.85x | 0.81x | 0.98x | 0.64x |
| Interest Paid | 20.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 40K | 0 | 0 | 39K | 5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |